statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	957
RU - Federazione Russa	216
IT - Italia	162
IE - Irlanda	130
SG - Singapore	122
CN - Cina	105
GB - Regno Unito	97
BR - Brasile	59
VN - Vietnam	58
HK - Hong Kong	41
SE - Svezia	40
DE - Germania	35
FR - Francia	34
UA - Ucraina	31
FI - Finlandia	22
BD - Bangladesh	18
ZA - Sudafrica	14
IN - India	13
KR - Corea	11
CA - Canada	10
AT - Austria	7
ES - Italia	7
MX - Messico	7
BE - Belgio	6
PL - Polonia	5
AU - Australia	3
NG - Nigeria	3
PK - Pakistan	3
AR - Argentina	2
CO - Colombia	2
CR - Costa Rica	2
EC - Ecuador	2
JM - Giamaica	2
JP - Giappone	2
NL - Olanda	2
NP - Nepal	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
BO - Bolivia	1
CH - Svizzera	1
CY - Cipro	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EG - Egitto	1
HN - Honduras	1
IL - Israele	1
IM - Isola di Man	1
IQ - Iraq	1
JO - Giordania	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LT - Lituania	1
LV - Lettonia	1
MA - Marocco	1
MD - Moldavia	1
MU - Mauritius	1
PE - Perù	1
PT - Portogallo	1
RO - Romania	1
SN - Senegal	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TR - Turchia	1
Totale	2.267

Nome	#
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy	261
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival	249
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016	239
Animal Resources and Subsistence Strategies	231
“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015	212
Structure-fucntion relationship of the NDM-1 metallo-beta-lactamase: Importance of Trp-87 in enzyme structure, function and stability.	206
Fifteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 5–7, 2017	206
Identification of immune correlates of clinical activity and/or disease outcome in melanoma patients undergoing targeted therapy	199
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines	168
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix	118
The Italian Network for Tumor Bio-Immunotherapy (NIBIT) Foundation: ongoing and prospective activities in immuno-oncology	114
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets	101
Totale	2.304

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	24	0	0	0	0	0	0	0	0	0	0	0	24
2021/2022	150	3	29	9	7	8	9	7	7	10	18	22	21
2022/2023	164	11	13	24	16	11	33	7	11	20	8	5	5
2023/2024	200	8	5	22	7	4	56	70	10	3	2	9	4
2024/2025	309	6	18	42	18	34	17	8	10	22	22	36	76
2025/2026	867	48	84	65	108	233	42	106	31	22	54	39	35
Totale													2.304